Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

WavoDyne Therapeutics

WavoDyne Therapeutics
Out of Business LATEST DEAL TYPE

Developer of therapeutic treatments designed to help patients suffering from memory impairment. The company's treatments include the development of drugs for memory and cognitive disorders resulting from neuroinflammatory processes, enabling patients to get advanced therapy for their disorders and recover faster.

Formerly Known As
Camber NeuroTheraputics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Lennox Tech Enterprise Center, 150 Lucius Gordon Drive
  • Suite 100
  • Rochester, NY 14586
  • United States

+1 (954) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore WavoDyne Therapeutics’s full profile, request a free trial.

WavoDyne Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 20-Dec-2017 Completed Out of Business
3. Early Stage VC Completed Startup
2. Angel (individual) 01-Nov-2015 $50K Cancelled Startup
1. Grant 31-Dec-2014 $32.4M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

WavoDyne Therapeutics Executive Team (1)

Name Title Board
Jim New Ph.D Founder, Chief Executive Officer & Chairman

WavoDyne Therapeutics Board Members (5)

Name Representing Role Since Contact
David Klein Self Board Member 000 0000
Jim New Ph.D WavoDyne Therapeutics Founder, Chief Executive Officer & Chairman 000 0000
Joseph Vacca Ph.D Self Board Member 000 0000
Karl Kieburtz MD Self Board Member 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »